Mylan's generic Wellbutrin XL enters market

PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.

Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.

The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.